ASCO Gastrointestinal Cancer Symposium | Conference

Kelley Lauren Coffman, MD, on Key Takeaways from a Study of 177Lu-DOTATATE in Well-Differentiated, High-Grade NETs
February 10, 2021

The hospitalist at Memorial Sloan Kettering Cancer Center discussed what she believes is most important for practicing oncologists to understand about a study of 177Lu-DOTATATE in well-differentiated, high-grade neuroendocrine tumors.

Kelley Lauren Coffman, MD, on the Next Steps for a Study of 177Lu-DOTATATE in Well-Differentiated, High-Grade NETs
February 07, 2021

The hospitalist at Memorial Sloan Kettering Cancer Center spoke about the next steps for a study which evaluated patients with well-differentiated, high-grade neuroendocrine tumors (NETs) who were treated with 177Lu-DOTATATE.

Pashtoon Murtaza Kasi, MD, MSc, on the Use of an AI-Driven Clinical Trial Support Tool
February 04, 2021

The novel search tool uses artificial intelligence to restructure trial information, making it easier for patients and providers to access clinical trial information.